ACCESS® 2 IMMUNOASSAY SYSTEM
Report
- Report Number
- 2122870-2013-00285
- Event Type
- Malfunction
- Date Received
- March 12, 2013
- Date of Event
- February 12, 2013
- Report Date
- February 12, 2013
- Manufacturer
- BECKMAN COULTER
- Product Code
- JJE
- PMA / PMN Number
- K922823/A007
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THE FIELD SERVICE ENGINEER (FSE) PERFORMED A DILUTED HUMAN CHORIONIC GONADOTROPHIN (DIL-HCG) PRECISION STUDY WITH A PERCENT COEFFICIENT OF VARIATION OF (%CV) OF 11.4%. THE FSE NOTED THE CUSTOMER REPLACED THE TRANSDUCER AND ULTRASONICS BOARD BUT DID NOT IMPROVE PERFORMANCE. THE FSE THEN REPLACED THE PRECISION PUMP AND PERFORMED A SECOND DIL-HCG PRECISION STUDY WITH A %CV OF 1.9%. THE FSE PROACTIVELY REPLACED THE INSTRUMENT WASH TOWER AND THE EXHAUST FAN AFTER OBSERVING SOME VISIBLE AND AUDIBLE ISSUES. SYSTEM CHECKS AND HIGH SENSITIVITY SYSTEM CHECKS WERE PASSED WITHIN SPECIFICATIONS PRIOR TO SERVICE. SERVICE ACTIVITY PERFORMED WAS VERIFIED TO MEET THE SPECIFIED REQUIREMENTS PER ESTABLISHED PROCEDURES. THE INSTRUMENT CONFORMED TO THE MANUFACTURER'S PUBLISHED SPECIFICATIONS. WASH TOWER. ALL RELATED MEDWATCH REPORTS ASSOCIATED WITH THIS INCIDENT: 2122870-2013-00284, 2122870-2013-00285, 2122870-2013-00286.
THE CUSTOMER REPORTED ERRATIC AND IMPRECISE DILUTED BETA HUMAN CHORIONIC GONADOTROPHIN (BHCG) RESULTS FOR THREE PATIENTS, ON SEPARATE DAYS, INVOLVING THE ACCESS 2 IMMUNOASSAY SYSTEM. SUBSEQUENT ANALYSES OF THE PATIENT'S SAMPLES, ON AN ALTERNATE ACCESS 2 SYSTEM, RECOVERED REPRODUCIBLE RESULTS THAT CORRELATED WITH THE PATIENT'S CLINICAL STATUS. THE ERRATIC RESULTS WERE NOT RELEASED OUT OF THE LABORATORY. THERE WAS NO PATIENT IMPACT ASSOCIATED WITH THIS EVENT. PATIENT SAMPLES WERE COLLECTED BY THE EMERGENCY DEPARTMENT (ED) STAFF IN 13X100 ML SERUM SEPARATION TUBES (SST) AND CENTRIFUGED AT 5,000 RPM (ROTATIONS PER MINUTE) FOR TEN MINUTES. THE CUSTOMER ALLOWS SAMPLES TO CLOT BETWEEN FIVE TO TEN MINUTES PRIOR TO CENTRIFUGATION. QUALITY CONTROL (QC) AND SYSTEM CHECK WERE WITHIN SPECIFICATIONS AT THE TIME OF THE EVENT. A BECKMAN COULTER FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO EVALUATE THE INSTRUMENT. THIS IS REPORT TWO OF THREE REFERENCING THE EVENT DATE NOTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 103213 | ACCESS® 2 IMMUNOASSAY SYSTEM | ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE | JJE | BECKMAN COULTER | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 17 YR |